Rock Springs Capital Management LP Q2 2017 Filing
Filed August 14, 2017
Portfolio Value
$2.0B
Holdings
148
Report Date
Q2 2017
Filing Type
13F-HR
All Holdings (148 positions)
| Stock | Value |
|---|---|
—ADURO BIOTECH INC | $4.7M |
—ALLERGAN PLC | $4.3M |
EX9EXELIXIS INC | $4.3M |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $4.1M |
OTICEUROTONOMY INC | $4.0M |
MGNXMACROGENICS INC | $3.9M |
ADAPYADAPTIMMUNE THERAPEUTICS PLC | $3.9M |
—MEDICINES CO | $3.9M |
HRCHILL ROM HLDGS INC | $3.6M |
AFWALIGN TECHNOLOGY INC | $3.5M |
—BLUEBIRD BIO INC | $3.4M |
CGENCOMPUGEN LTD | $3.1M |
ALKSALKERMES PLC | $3.0M |
—AXOVANT SCIENCES LTD | $2.9M |
BMYBRISTOL MYERS SQUIBB CO | $2.8M |
RIGLUSDRIGEL PHARMACEUTICALS INC | $2.7M |
ZBHZIMMER BIOMET HLDGS INC | $2.7M |
—DBV TECHNOLOGIES S A | $2.6M |
GKOSGLAUKOS CORP | $2.6M |
INVAINNOVIVA INC | $2.6M |
HQYHEALTHEQUITY INC | $2.5M |
GLYCEURGLYCOMIMETICS INC | $2.5M |
—GENOCEA BIOSCIENCES INC | $2.5M |
MCRB1EURSERES THERAPEUTICS INC | $2.5M |
ITCIEURINTRA CELLULAR THERAPIES INC | $2.3M |
—CIDARA THERAPEUTICS INC | $2.3M |
—PROTEOSTASIS THERAPEUTICS IN | $2.1M |
—ALDER BIOPHARMACEUTICALS INC | $2.1M |
—THERAVANCE BIOPHARMA INC | $2.0M |
AGLEUSDAEGLEA BIOTHERAPEUTICS INC | $2.0M |
—NOVADAQ TECHNOLOGIES INC | $1.8M |
—MYOVANT SCIENCES LTD | $1.8M |
—ATYR PHARMA INC | $1.6M |
DVAXDYNAVAX TECHNOLOGIES CORP | $1.6M |
—NIVALIS THERAPEUTICS INC | $1.4M |
SCYXEURSCYNEXIS INC | $1.4M |
—WRIGHT MED GROUP INC | $1.1M |
NVAXNOVAVAX INC | $943K |
PRGOPERRIGO CO PLC | $740K |
—CHIASMA INC | $714K |
—EGALET CORP | $711K |
—NEWLINK GENETICS CORP | $533K |
—OREXIGEN THERAPEUTICS INC | $479K |
—TANDEM DIABETES CARE INC | $450K |
INFIQINFINITY PHARMACEUTICALS INC | $424K |
—DIMENSION THERAPEUTICS INC | $393K |
—CERULEAN PHARMA INC | $276K |
ANTHANTHERA PHARMACEUTICALS INC | $268K |
PreviousPage 2 of 2